-
Signature
-
/s/ Christopher Krueger, as Attorney-in-Fact
-
Issuer symbol
-
VTYX
-
Transactions as of
-
31 Aug 2023
-
Net transactions value
-
-$223,639
-
Form type
-
4
-
Filing time
-
01 Sep 2023, 16:45:47 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
VTYX |
Common Stock |
Options Exercise |
$176,715 |
+11,900 |
+25% |
$14.85 |
60,289 |
31 Aug 2023 |
Direct |
|
| transaction |
VTYX |
Common Stock |
Sale |
$400,354 |
-11,900 |
-20% |
$33.64 |
48,389 |
31 Aug 2023 |
Direct |
F1, F2 |
| holding |
VTYX |
Common Stock |
|
|
|
|
|
24,194 |
31 Aug 2023 |
By Spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
VTYX |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-11,900 |
-1.8% |
$0.000000 |
664,300 |
31 Aug 2023 |
Common Stock |
11,900 |
$14.85 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
President and Chief Medical Officer